Our discovery that CD5 KD caused T cell-dependent wasting disease associated with gut immune dysregulation prompted us to ask if the loss of CD5 would exacerbate colitis in experimental models for inflammatory bowel disease (IBD). This evidence concerns the gene CD5 and inflammatory bowel disease.